3.0
2 Mar 2017
Current employee, more than 3 years
Tuas,
Recommend
CEO approval
Business outlook
Pros
Big company with mature processes and systems in place. Pipeline is going to be profitable with ventures into oncology medicines
Cons
- Very stingy to the staff and management in Singapore but splurging at other continents. - Senior is squeezing the employees till the last drop but willing to look into their welfare - Slave-driver mentality and MSD is no longer considered a good employer in the Pharmaceutical industry